Genetically Stratifying Smoking-Cessation Trials Could Save Up to $15M, Researchers Find

The findings could offer insight into the circumstances in which genotyping patients may be cost-effective in smoking cessation studies while also informing the design of studies for other disease indications.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories